Symbiotec Pharmalab IPO — Listing Performance
Symbiotec Pharmalab IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 24 Aug 2026 |
| Listing date | 1 Sep 2026 |
| Issue price | ₹988 |
| Listing-day close | ₹1,097.70 (11.1%) |
| Recent market price | ₹1,246.30 (26.14% vs issue) |
| 52-week range | ₹1,076.85 – ₹1,098.70 |
| Identifiers | NSE: SYMBIOTEC · ISIN: INE899I01028 |
How the listing went
Symbiotec Pharmalab saw a healthy listing pop, closing day one 11.1% above the issue price.
Symbiotec Pharmalab against every other debut on record
- Rank in 2026: 64 of 165 NSE debuts, on a 11.1% first-day close.
- 54th percentile of 101 mainboard debuts in 2026 (median 8.51%).
- 20th of 42 debuts in September 2026.
- Opened 0% above issue, then added 11.1 points to the close.
- Day-one range ₹934.20 to ₹1,180: a 24.88% swing on the issue price.
- Last close ₹1,246.30 (30 Oct 2026): 26.14% above issue, against 11.1% on day one.
- 1% up its 52-week range of ₹1,076.85 to ₹1,098.70.
- Priced at the top of the ₹938 to ₹988 band.
- Listed 5 calendar days after close.
- All 547 mainboard debuts on record: median 11.6%, 72% closed above issue.
Computed over 1161 verified NSE debuts to 28 Oct 2026 · sources